Robert Lyne

Robert Lyne

Director Ejecutivo en PURETECH HEALTH PLC .

Fortuna: 230 857 $ al 30/09/2026

43 años
Finance
Consumer Services
Commercial Services

Perfil

Robert William Henry Lyne is currently Chief Executive Officer & Director at PureTech Health Plc starting in 2025.
He is CEO and General Counsel at Arix Bioscience since 2021.
He serves as Director at Arix Bioscience Holdings Ltd. since 2017, Director at Seaport Therapeutics, Inc., and Board Member at Arix Capital Management Ltd. Formerly, Mr. Lyne was Chief Executive Officer at Arix Bioscience Plc from 2021 to 2023 and worked as an Associate at Bird & Bird LLP.
Education includes undergraduate studies at the University of Oxford and graduate studies at Oxford Brookes University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
08/07/2026 151.112 ( 0,06 % ) 230 857 $ 30/09/2026

Cargos activos de Robert Lyne

EmpresasCargoInicio
PURETECH HEALTH PLC Director Ejecutivo 15/07/2025
Director/Miembro de la Junta -
Director Ejecutivo 01/10/2021
Director/Miembro de la Junta 06/12/2017

Antiguos cargos conocidos de Robert Lyne.

EmpresasCargoFin
ARIX BIOSCIENCE PLC Director Ejecutivo 01/12/2023
Corporate Officer/Principal -
Ver el detalle de la experiencia de Robert Lyne.

Formación de Robert Lyne.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

52

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Consumer Services

Consumer Services

Commercial Services

Finance

Health Technology

Finance

Health Services

Finance